Partner Headlines - IBB

  1. 2 Biotech Funds Leading Nascent Bull Market: Which Is Right For ...

    Investors Business Daily
  2. This Week Could Decide Whether Biotech ETFs' Rally Sizzles Or ...

    Investors Business Daily
  3. Illumina Brings More Pain To Battered Biotech ETFs; Gold Hits ...

    IBD
  4. TickerTags Data Shows Drug Price Debate Still Trending

    Benzinga
  5. Even With Volatility, Investors Love Biotech ETFs

    Benzinga
  6. Equal Weighting Works For This Industry ETF

    Benzinga
  7. Biotechs Sell Off Hard, But Indexes Cut Their Losses

    IBD
  8. Biotech ETFs: Buy, Buy, Buy?

    Benzinga
  9. Social Media Beat: What Experts And The Crowd Think Of Biotechs, ...

    Benzinga
  10. Biotech Bears Spark Good Vibes For These ETFs

    Benzinga
  11. Techs Erase Early Gains; Apple, Facebook Lead Nasdaq 100 Lower

    IBD
  12. Small-Cap Healthcare ETF: A Baby Thrown Out With The Bathwater

    Benzinga
  13. The Weak Get Weaker In The Options Market

    Benzinga
  14. Fast Money Picks For September 22

    Benzinga
  15. This Week In Options: Where Is The Rally?

    Benzinga
  16. Why Biotech & Healthcare Are The Biggest Risks To The Market

    Benzinga
  17. The Other Bearish Biotech ETF Is Looking Groovy, Too

    Benzinga
  18. IBB Holding Early Morning Lows

    Benzinga
  19. Fast Money Picks For August 18

    Benzinga
  20. This Week's ETF's To Watch: A Lot Of Familiar Faces

    Benzinga
  21. A Bad Week For Biotech Was Great For This ETF

    Benzinga
  22. China, Greece Don't Derail ETF Inflows In July

    Benzinga
  23. Even With Recent Declines, Investors Still Love Biotech ETFs

    Benzinga
  24. These 4 Foreign Drug Stocks Have Broken Out Recently

    IBD
  25. Caution Continues In Options Market This Week

    Benzinga
  26. A Big Day For Biotech And It's Not Going So Well

    Benzinga
  27. A Look Ahead: Biotech And Energy ETFs To Watch This Week

    Benzinga
  28. Vista Partners Initiates Coverage on Immune Pharmaceuticals Inc. ...

    GuruFocus
  29. As Biotech Beats, 6 Top ETF Picks For Rest Of 2015

    IBD
  30. ProShares Releases 2 New Leveraged Biotech ETFs

    Benzinga
  31. Biotech ETFs Hit New 2015 Highs

    Benzinga
  32. Investment Strategies for the Bullish Biotech Sector

    GuruFocus
  33. 'Don't Give Up On Biotech Yet,' Says This CFA

    Benzinga
  34. Making Money With Charles Payne: 05/1/15

    FoxBusiness
  35. Nasdaq Leads Market Lower As Medical Stocks Tumble

    IBD
  36. Technology, Inflation Protection And Biotech ETFs To Watch This ...

    Benzinga
  37. How To Invest In ETFs: Tips To Trade Top Market Trends

    IBD
  38. Social Media Analytics: 3 ETFs Recently Blowing Up On Twitter

    Benzinga
  39. The Best Biotech ETF Isn't Always The Biggest

    Benzinga
  40. Biotech Stocks Moving Higher

    Benzinga
  41. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga
  42. Top 5 Biotech Stocks That The Smart Money Doesn't Like

    Benzinga
  43. iShares NASDAQ Biotech ETF Pulls Back Off All-Time Highs

    Benzinga
  44. Making Money With Charles Payne: 01/14/15

    FoxBusiness
  45. Are There Any Winners Left In The Biotech Space?

    Benzinga
  46. Biotech Stocks Sell Off, ETFs Fall Over 5%

    Benzinga
  47. Making Money With Charles Payne: 12/22/14

    FoxBusiness
  48. 3 Biotech ETFs Rally On Merger News

    Benzinga
  49. A Look At 3 Overbought ETFs

    Benzinga
  50. 1 Biotech Beast Worth Tracking

    Benzinga
  51. Best And Worst ETFs Of The Week Amid Biotech Breakout

    Benzinga
  52. Arrowhead Research Corp Heads Higher After Breakout

    Benzinga
  53. Biotechnology, Oil And Brazil ETFs To Watch This Week

    Benzinga
  54. Isis Pharmaceuticals Finally Breaks Out

    Benzinga
  55. Yellen Says Social Media, Biotech Stocks 'Substantially Stretched'

    Benzinga
  56. 4 ETFs With Upside Potential

    Benzinga
  57. Dow Closes At A New High As Late-Month Rally Boosts Stocks

    Benzinga
  58. Johnson & Johnson: Why Top Funds Are Buying

    YCharts
  59. Stocks Revisit Session Lows; Share Offer Lifts GasLog

    IBD
  60. Don't Panic Over Recent Tech Turmoil

    FoxBusiness
  61. Despite S&P 500's New High, Stocks Face Challenges

    Benzinga
  62. Biotech ETFs Come Back Down To Earth

    Benzinga
  63. ETF Outlook For Wednesday, March 26, 2014 (IBB, IPO, FPX, SOCL, ...

    Benzinga
  64. ETF Outlook For The Week Of March 24, 2014 (IBB, CARZ, RSX, GM)

    Benzinga
  65. Stocks Edge Lower In Dull Session; Biogen Idec Hangs Tough

    IBD
  66. Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT)

    Benzinga
  67. Biotech And Natural Gas ETFs On A Roll

    Benzinga
  68. ETF Outlook For The Week Of February 10 (IBB, VXZ, GREK, GDX)

    Benzinga
  69. Sector ETFs Breaking Out (IBB, IHE, XLV, IAT, SKYY)

    Benzinga
  70. ETF Outlook for Friday, December 20 (REM, USO, IBB, FCG)

    Benzinga
  71. The One True Sector Bubble: Profits Here When It Crashes Soon

    Benzinga
  72. ETF Outlook for Tuesday, November 26, 2013

    Benzinga
  73. Biotech ETFs Plummeting (XBI, IBB, BBH)

    Benzinga
  74. Biotech Breakout Highlights Flawed ETF Thinking

    Benzinga
  75. Three Soaring, But Overlooked Health Care ETFs

    Benzinga
  76. Seasonal Trends: Three ETFs To Own In August

    Benzinga
  77. Three ETFs That Have Blown Past Their 200-Day Lines

    Benzinga
  78. ETFs to Watch July 29, 2013 (BOND, EWJ, IBB)

    Benzinga
  79. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga
  80. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga
  81. Use The Sharpe Ratio For Profits With These ETFs

    Benzinga
  82. 4 Health Care ETFs Your Broker Forgot to Mention

    Benzinga
  83. Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)

    Benzinga
  84. These ETFs Are Awash in 2013 Takeover Targets

    Benzinga
  85. Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)

    Benzinga
  86. Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)

    Benzinga
  87. S&P Likes a Trio of Biotech ETFs

    Benzinga
  88. ETFs to Watch October 23, 2012 (FCF, IBB, EWT)

    Benzinga
  89. Investors Cheating Themselves by Focusing on Largest ETFs

    Benzinga
  90. Three Biotech Stocks Analysts Are Keen On (ARIA, MACK, GEVA)

    Benzinga
  91. When Cheaper Is Better With ETFs

    Benzinga
  92. Possible Hepatitis C Outbreak Could Lift This ETF

    Benzinga
  93. Low Volume, High Returns for These ETFs (BIB, FHC, DRW)

    Benzinga
  94. Small-Cap Corner: A Forgotten Biotech ETF

    Benzinga
  95. ETFs to Watch July 3, 2012 (TNA, XLB, PCY)

    Benzinga
  96. Arena Approval Boosts Biotech ETFs (ARNA, IBB, XBI)

    Benzinga
  97. The Definitive Biotech ETF Guide (IBB, XBI, FBT)

    Benzinga
  98. 4 High P/E ETFs (IBB, IGV, PNQI)

    Benzinga
  99. S&P Bullish On Biotech ETFs (FBT, IBB, XBI)

    Benzinga
  100. 4 Ignored ETFs Up More Than 20% YTD (GERJ, VROM, TAO)

    Benzinga
Trading Center